Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows Post author: Post published:June 4, 2024 Post category:uncategorized Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells. You Might Also Like Nanoparticles turbocharge turmeric’s curcumin for enhanced health benefits March 17, 2024 Children battling meningitis face lifelong disability, study finds January 18, 2024 Marijuana use linked to elevated nicotine levels in plastic surgery patients August 29, 2024